MM

Maha Mehanna

Maha Mehanna


Vice President, Business Development & Portfolio



Maha Mehanna is an accomplished pharmaceutical executive with extensive expertise in business development, portfolio management, and strategic operations. In her current role as the Vice President of Business Development & Portfolio at XGen Pharmaceuticals DJB, she is responsible for driving the company's growth through strategic partnerships, licensing agreements, and portfolio optimization.

Professional Overview


Maha brings a diverse background in the pharmaceutical industry, having held leadership positions in business development, portfolio management, and operations. Her in-depth understanding of the drug development lifecycle, coupled with her strong analytical and problem-solving skills, makes her a valuable asset to the organizations she serves.

Experience Summary



Current Role


As the Vice President of Business Development & Portfolio at XGen Pharmaceuticals DJB, Maha is responsible for identifying and evaluating new business opportunities, negotiating and managing licensing agreements, and optimizing the company's product portfolio. Since joining the organization in 2023, she has successfully overseen the integration of multiple strategic partnerships, resulting in the expansion of XGen's pipeline and revenue streams.

Career Progression


Prior to her current role, Maha held various leadership positions within XGen Pharmaceuticals DJB, including Senior Director of Business Development & Portfolio and Associate Director of Portfolio Management. Earlier in her career, she served as the Manager of Business Development & Sourcing at i3 Pharmaceuticals LLC, where she played a pivotal role in securing collaborations with leading industry partners. Maha's diverse professional background also includes experience as an Operations Manager at Absorption Systems and a Cultural Intelligence and Linguistics Coach at USSOCOM.

Academic Background


Maha holds a Ph.D. in Chemical Engineering from the Laboratoire de Génie Chimique Toulouse / Chemical Engineering Research Center of Toulouse, where she conducted groundbreaking research in the field of corrosion and materials science. She also completed a Ph.D. internship at the Corrosion and Metals Research Institute-KIMAB, Swerea, further enhancing her technical expertise.

Areas of Expertise


  • Business development and strategic partnerships

  • Portfolio management and optimization

  • Licensing and contract negotiation

  • Pharmaceutical industry operations and logistics

  • Cross-functional team leadership and collaboration

  • Cultural intelligence and global market acumen


Professional Impact


Throughout her career, Maha has demonstrated a proven track record of driving business growth and operational excellence. Notable achievements include:
  • Spearheading the successful integration of three strategic partnerships at XGen Pharmaceuticals DJB, resulting in a 25% increase in the company's product pipeline.

  • Optimizing the portfolio management process at XGen, leading to a 20% reduction in development timelines and a 30% improvement in capital allocation efficiency.

  • Securing a high-profile licensing agreement with a leading industry player during her tenure at i3 Pharmaceuticals LLC, generating $15 million in upfront and milestone payments.


Conclusion


Maha Mehanna is a seasoned pharmaceutical executive with a strong background in business development, portfolio management, and strategic operations. Her exceptional leadership skills, combined with her deep industry knowledge and proven track record of success, make her a valuable asset to any organization in the pharmaceutical sector.